EN
The study involved the estimation of the prevalence of Entamoebaspp. using microscopy and moleculartechniques among symptomatic outpatients from April 2021 to March, 2022. Stool samples were collected from 2592outpatients with amoebosis symptoms of both sexes and different ages (≤ l to 60). Also, 207 stool samples were takenrandomly from asymptomatic individuals and examined microscopically to detect infection with Entamoebaspp. thepositive specimens were used for molecular analysis with positive symptomatic samples targeting the 18S rRNA geneby nested PCR. Microscopically 21.68% (562/2592) were positive, for Entamoebaspp. Males showed highest infectionrate than females (67.43% vs 32.56%). Ages from 1–10 years showed the highest rate (54.09%), and urban inhabitanthad somewhat a higher rate than rural one (58.54% vs 41.45%) which was statistically non-significant (P>0.05). Amongasymptomatic individuals, 57% (61/107) were positive for Entamoebaspp. Nested PCR analysis yielded 73% positivesamples for Entamoebaspp. with a fragment size of 897 bp. Three fragment sizes were produced, for E. histolytica, E.disparand E. moshkovskiiwhich were 439, 174 and 553 bps, respectively. Single infection occurred with, E. histolyticain 46%, of symptomatic and 6% of asymptomatic cases, E. dispar in 38% of asymptomatic and 10% of symptomaticcases, E. moshkovskii, was reported at very low rate among both groups.